Glucagon-Like Peptide-1 Agonists (GLP-1) By Paul Gilbert, MD, Internal Medicine Residency Class of 2025 Note: This is a series called “Clinical Pearls,” where physicians will share treatment tips for specificLEARN MORE
What’s new: The HonorHealth Microbiology Laboratory accreditation program (CAP) has updated requirements for antibiotic reporting. CAP requires that laboratories must document all breakpoints in use by MIC or disk diffusionLEARN MORE
At HonorHealth, we are dedicated to helping patients live a healthy life. An endoscopic bariatric approach may be the right option if your patient has been trying to lose weightLEARN MORE
The 2023 viral season has begun, and with that, the viral-to-viral impact has affected transmissibility and the viral pattern. We are starting to learn more about the new viral seasonalLEARN MORE
As you’ve likely heard on the news or through medical publications, there is currently a nationwide shortage of chemotherapy drugs used to treat certain types of cancer. This is dueLEARN MORE
In Arizona, five people die each day due to an opioid overdose. According to the Arizona Department of Health Services (AZDHS), opioid abuse and addiction have reached an all-time highLEARN MORE
Maricopa County has identified its first case of West Nile (WNV) virus for 2023. Practitioners evaluating patients presenting with the following symptoms should consider both WNV and St. Louis encephalitisLEARN MORE
Standard precautions are essential for all aspects of patient care to reduce the spread of unknown illnesses. Many people are colonized with MRSA, yeast species, E. coli and other pathogenicLEARN MORE
The John C. Lincoln Infection Prevention Department has conducted a study on the emerging pathogen known as Candida auris (C. auris). Read the full report which outlines prevalence, transmission, whoLEARN MORE
Long-Covid ECHO: How to treat your patients with long term COVID syndrome using evidence based practices Supported by the Maricopa County Department of Public Health and the Centers for DiseaseLEARN MORE
